e-learning
resources
Paris 2018
Tuesday, 18.09.2018
CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of a specialist respiratory pharmacist in the management of interstitial lung disease
M. Naqvi (London, United Kingdom), G. D'Ancona (London, United Kingdom), A. West (London, United Kingdom)
Source:
International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session:
CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session type:
Poster Discussion
Number:
3667
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Naqvi (London, United Kingdom), G. D'Ancona (London, United Kingdom), A. West (London, United Kingdom). Impact of a specialist respiratory pharmacist in the management of interstitial lung disease. 3667
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
Impact of early referral to palliative care in patients with interstitial lung disease
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease
Source: Eur Respir J 2013; 42: 444-453
Year: 2013
Impact of a primary care based multidisciplinary respiratory team on hospital admission rates for patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006
Contemporary challenges for specialist nursing in interstitial lung disease
Source: Breathe, 14 (1) 36; 10.1183/20734735.014917
Year: 2018
Home management of chronic respiratory disease through the use of telemedicine
Source: Annual Congress 2009 - MP18 - Home management of chronic respiratory disease through the use of telemedicine
Year: 2009
Audit of acute admissions of COPD: standards of care and management in the hospital setting
Source: Eur Respir J 2001; 17: 343-349
Year: 2001
Optimising inpatient resources: role of a domiciliary COPD care management programme
Source: Annual Congress 2005 - Chronic care in respiratory failure
Year: 2005
Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care
Source: Eur Respir J 2008; 32: 945-952
Year: 2008
EPIDIA: an App to to assist physicians in the care of patients with interstitial lung diseases
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Multidisciplinary management for peadiatric chronic respiratory disease
Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases
Year: 2004
Out-patient pulmonary rehabilitation program reduce hospital utilisation in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 593s
Year: 2002
Palliative and end-of-life care for patients with respiratory disease
Source: Eur Respir Mon; 2009: 43:327–353
Year: 2009
Effect of primary-care spirometry on the diagnosis and management of COPD
Source: Eur Respir J 2006; 28: 945-952
Year: 2006
Global characterisation of routine care interstitial lung disease diagnostic practice
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Efficacy of home-based pulmonary rehabilitation program for the patients with chronic lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 164s
Year: 2003
Clinical benefits of a combined hospital and home-based exercise program in patients with interstitial lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 371s
Year: 2006
Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure
Source: Breathe, 15 (3) 227; 10.1183/20734735.0186-2019
Year: 2019
Comparison of efficacy of respiratory rehabilitation in patients with COPD and interstitial lung disease
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
The role of a trained respiratory physician in lung cancer management
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept